JCNRJournal of Clinical and Nursing Research2208-36852208-3693Bio-Byword Scientific Publishing Pty. Ltd.10.26689/jcnr.v10i2.14096ArticleA Case Report and Analysis: Hereditary Hemochromatosis Caused by a Splice Site Mutation in the HFE Genehttps://artdesignp.com/journal/JCNR/10/2/10.26689/jcnr.v10i2.14096YanQian,WangYaling,XiangZhaoqiang,ChenXiaomin,HuangChunlan20261022026-03-10Hereditary hemochromatosis (HH) is defined as an autosomal recessive iron metabolism disorder, typically characterized by excessive iron absorption leading to iron overload in multiple organs, particularly the liver, heart, and endocrine glands. Clinical manifestations commonly include diabetes, skin pigmentation, cirrhosis, abdominal pain, arthralgia, and fatigue. Mutations in the HFEgene, located on chromosome 6p22, have been identified as the primary genetic basis of HH. This gene encodes a protein critical for iron absorption and metabolism. Studies indicate that HH is most prevalent in European populations but rare in Asians. Due to reduced iron accumulation from menstrual blood loss in females, the disease predominantly affects adult males, with females often developing symptoms post-menopause. This article reports a rare case of HHin a premenopausal Chinese female caused by a homozygous HFE gene mutation (c.340 + 4T > C). The patient presented with chronic fatigue, abdominal pain, and lower limb petechiae. Diagnosis was confirmed via clinical evaluation, laboratory tests, and genetic analysis. This study identifies a novel pathogenic mutation in the Chinese population, contributing to early diagnosis and treatment of HH.

Katsarou M, Papasavva M, Latsi R, et al., 2019, Hemochromatosis: Hereditary Hemochromatosis and HFE Gene. Vitamins and Hormones, 110: 201–222.

Piperno A, Pelucchi S, Mariani R, 2020, Inherited Iron Overload Disorders. Translational Gastroenterology and Hepatology, 5: 25.

Hanson E, Imperatore G, Burke W, 2001, HFE Gene and Hereditary Hemochromatosis: A HuGE Review. American Journal of Epidemiology, 154: 193–206.

Adams P, Reboussin D, Barton J, et al., 2005, Hemochromatosis and Iron-Overload Screening in a Racially Diverse Population. New England Journal of Medicine, 352: 1769–1778.

Porto G, Brissot P, Swinkels D, et al., 2016, EMQN Best Practice Guidelines for the Molecular Genetic Diagnosis of Hereditary Hemochromatosis (HH). European Journal of Human Genetics, 24: 479–495.

Girelli D, Busti F, Brissot P, et al., 2022, Hemochromatosis Classification: Update and Recommendations by the BIOIRON Society. Blood, 139: 3018–3029.

Barton J, Edwards C, Acton R, 2015, HFE Gene: Structure, Function, Mutations, and Associated Iron Abnormalities. Gene, 574: 179–192.

Kawabata H, Fleming R, Gui D, et al., 2005, Expression of Hepcidin Is Down-Regulated in TfR2 Mutant Mice Manifesting a Phenotype of Hereditary Hemochromatosis. Blood, 105: 376–381.

Salter-Cid L, Brunmark A, Li Y, et al., 1999, Transferrin Receptor Is Negatively Modulated by the Hemochromatosis Protein HFE: Implications for Cellular Iron Homeostasis. Proceedings of the National Academy of Sciences of the United States of America, 96: 5434–5439.

Bridle K, Frazer D, Wilkins S, et al., 2003, Disrupted Hepcidin Regulation in HFE-Associated Haemochromatosis and the Liver as a Regulator of Body Iron Homoeostasis. Lancet, 361: 669–673.

Nicolas G, Bennoun M, Devaux I, et al., 2001, Lack of Hepcidin Gene Expression and Severe Tissue Iron Overload in Upstream Stimulatory Factor 2 (USF2) Knockout Mice. Proceedings of the National Academy of Sciences of the United States of America, 98: 8780–8785.

Pietrangelo A, 2010, Hereditary Hemochromatosis: Pathogenesis, Diagnosis, and Treatment. Gastroenterology, 139: 391–408.

Katsarou M, Latsi R, Papasavva M, et al., 2016, Population-Based Analysis of the Frequency of HFE Gene Polymorphisms: Correlation with the Susceptibility to Develop Hereditary Hemochromatosis. Molecular Medicine Reports, 14: 630–636.

Marjot T, Collier J, Ryan J, 2016, What Is HFE Haemochromatosis? British Journal of Hospital Medicine (London), 77: C91–C95.

Bardou-Jacquet E, Morcet J, Manet G, et al., 2015, Decreased Cardiovascular and Extrahepatic Cancer-Related Mortality in Treated Patients with Mild HFE Hemochromatosis. Journal of Hepatology, 62: 682–689.

Ye K, Cao C, Lin X, et al., 2015, Natural Selection on HFE in Asian Populations Contributes to Enhanced Non-Heme Iron Absorption. BMC Genetics, 16: 61.